Strategic Design and Engineering of CRISPR/Cas-Powered Sensing Platforms for Enhanced Nucleic Acid Detection
ACS Sensors · 24.07.2026 · 11 (7) · 5342-5359
DOI: 10.1021/acssensors.6c01710 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Sensors, online erschienen am 06.07.2026. Verfasst von Songkuan Zhuang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Nanosensor Molecular Diagnostic & Treatment Technology, Shenzhen Key Laboratory of Nano-Biosensing Technology, College of Chemist…. Hauptthemen laut MEDLINE: Biosensing Techniques, CRISPR-Cas Systems, Nucleic Acids, DNA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 111 Literaturangaben. Gefördert von: Science and Technology Foundation of Shenzhen City, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Rapid and accurate nucleic acid detection is fundamental to effective disease management. While PCR remains the gold standard, its requirement for sophisticated instrumentation limits its application in point-of-care settings. CRISPR-Cas systems have emerged as a disruptive diagnostic technology, leveraging the programmable specificity and unique trans-cleavage activity of Cas effectors to revolutionize biosensing. This review systematically evaluates the evolution of CRISPR-Cas-powered sensing platforms, categorized by their signal transduction modalities. We first discuss the expanding biochemical landscape of Cas nucleases, highlighting recent discoveries where conventional boundaries of Cas9, Cas12, and Cas13 have been transcended to enable versatile DNA/RNA targeting. Subsequently, we provide a comprehensive analysis of four primary sensing architectures: (1) Fluorescence-based platforms, exploring diverse strategies from target and signal amplification with dual-labeled ssDNA probes to nanomaterial-based probes; (2) Naked-eye visual platforms, encompassing both solid-phase lateral flow assays and solution-phase colorimetric strategies that facilitate rapid, instrument-free screening; (3) Electrochemical biosensors, which transduce biological recognition events into measurable electrical parameters, offering high sensitivity and seamless integration with miniaturized electronics; and (4) Electronic and Optoelectronic systems, including field-effect transistors and plasmonic sensors, which offer high-sensitivity, label-free detection. Despite significant progress, the translation of CRISPR-Dx from laboratory proof of concepts to clinical reality faces several bottlenecks. We critically analyze current challenges, including the need for integrated "sample-to-answer" workflows, high-throughput multiplexing, and digital quantification. Finally, we envision future trends such as AI-assisted signal processing and wearable sensing interfaces. By bridging the gap between molecular biology and advanced engineering, CRISPR-powered platforms are poised to make precision molecular diagnostics universally accessible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Nanosensor Molecular Diagnostic & Treatment Technology, Shenzhen Key Laboratory of Nano-Biosensing Technology, College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen, Guang…
ORCID-Profile: Yizhen Liu
Förderung
- Science and Technology Foundation of Shenzhen City
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Zhuang, S., Luo, W., Lan, B., & Liu, Y. (2026). Strategic Design and Engineering of CRISPR/Cas-Powered Sensing Platforms for Enhanced Nucleic Acid Detection. ACS Sensors, 11(7), 5342-5359. https://doi.org/10.1021/acssensors.6c01710
Vancouver
Zhuang S, Luo W, Lan B, Liu Y. Strategic Design and Engineering of CRISPR/Cas-Powered Sensing Platforms for Enhanced Nucleic Acid Detection. ACS Sensors. 2026;11(7):5342-5359. doi:10.1021/acssensors.6c01710
BibTeX
@article{Zhuang2026,
author = {Zhuang, Songkuan and Luo, Weilin and Lan, Beiyi and Liu, Yizhen},
title = {Strategic Design and Engineering of CRISPR/Cas-Powered Sensing Platforms for Enhanced Nucleic Acid Detection},
journal = {ACS Sensors},
year = {2026},
volume = {11},
number = {7},
pages = {5342--5359},
doi = {10.1021/acssensors.6c01710}
}
EUVIMED